Further, analysis of the correlation between GAD1 and the prostate cancer immune microenvironment indicated that GAD1 expression and methylation were significantly associated with many immune indicators, including lymphocytes, immunoinhibitors, immunostimulators, MHC molecules, chemokines and chemokine receptors. The gene discussed is GAD1; the disease is prostate cancer.